Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare OTCMKTS:HPPI NYSEMKT:IGC OTCMKTS:INBP NASDAQ:SNYR On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeHPPIHedgePath Pharmaceuticals$0.06$0.05$0.04▼$0.32$32.16M-1.1619,283 shs6,000 shsIGCIGC Pharma$0.36+11.0%$0.34$0.25▼$0.48$33.15M1.48913,992 shs214,616 shsINBPIntegrated BioPharma$0.26$0.31$0.17▼$0.42$8.13M0.89,327 shsN/ASNYRSynergy CHC$2.94+1.4%$3.23$1.19▼$10.00$27.76MN/A47,397 shs80,384 shsThese 7 Stocks Will Be Magnificent in 2025Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceHPPIHedgePath Pharmaceuticals+12.32%+44.75%+5.85%-1.70%-20.66%IGCIGC Pharma0.00%-1.63%-3.72%+7.74%-8.01%INBPIntegrated BioPharma0.00%-1.43%-7.99%-20.69%+31.25%SNYRSynergy CHC0.00%-14.29%-25.94%+50.00%+9,700.00%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationHPPIHedgePath PharmaceuticalsN/AN/AN/AN/AN/AN/AN/AN/AIGCIGC Pharma1.7575 of 5 stars3.50.00.00.01.81.70.0INBPIntegrated BioPharmaN/AN/AN/AN/AN/AN/AN/AN/ASNYRSynergy CHC4.3674 of 5 stars3.80.00.00.02.83.33.1Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceHPPIHedgePath Pharmaceuticals 0.00N/AN/AN/AIGCIGC Pharma 3.00Buy$3.88970.44% UpsideINBPIntegrated BioPharma 0.00N/AN/AN/ASNYRSynergy CHC 3.50Strong Buy$10.00240.14% UpsideCurrent Analyst Ratings BreakdownCompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookHPPIHedgePath PharmaceuticalsN/AN/AN/AN/A($0.01) per shareN/AIGCIGC Pharma$1.33M24.77N/AN/A$0.08 per share4.53INBPIntegrated BioPharma$50.32M0.16$0.04 per share5.93$0.64 per share0.41SNYRSynergy CHC$34.83M0.80$0.27 per share11.05($1.31) per share-2.24Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateHPPIHedgePath Pharmaceuticals-$4.55MN/A0.00∞N/AN/AN/A-246.03%N/AIGCIGC Pharma-$13M-$0.07N/AN/AN/A-714.16%-122.44%-88.40%N/AINBPIntegrated BioPharma$110K$0.046.56∞N/A2.37%6.36%4.84%9/18/2025 (Estimated)SNYRSynergy CHC$2.12M$0.387.744.98N/A10.02%-18.56%20.28%N/ALatest INBP, SNYR, IGC, and HPPI EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/14/2025Q2 2025SNYRSynergy CHC$0.08$0.17+$0.09$0.17$10.80 million$6.74 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthHPPIHedgePath PharmaceuticalsN/AN/AN/AN/AN/AIGCIGC PharmaN/AN/AN/AN/AN/AINBPIntegrated BioPharmaN/AN/AN/AN/AN/ASNYRSynergy CHCN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioHPPIHedgePath PharmaceuticalsN/A6.766.76IGCIGC Pharma0.021.150.98INBPIntegrated BioPharmaN/A3.721.70SNYRSynergy CHCN/A2.741.62Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipHPPIHedgePath PharmaceuticalsN/AIGCIGC Pharma3.87%INBPIntegrated BioPharma25.25%SNYRSynergy CHCN/AInsider OwnershipCompanyInsider OwnershipHPPIHedgePath Pharmaceuticals4.80%IGCIGC Pharma31.48%INBPIntegrated BioPharma67.20%SNYRSynergy CHC56.60%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableHPPIHedgePath Pharmaceuticals1370.45 millionN/ANot OptionableIGCIGC Pharma6190.81 million54.60 millionN/AINBPIntegrated BioPharma15030.98 million10.16 millionNot OptionableSNYRSynergy CHC409.44 million4.10 millionN/AINBP, SNYR, IGC, and HPPI HeadlinesRecent News About These CompaniesSynergy CHC's (NASDAQ:SNYR) Earnings Quality Is LowAugust 22 at 10:03 AM | finance.yahoo.comSynergy CHC Corp to Present at the 2025 Gateway Conference on September 4thAugust 21 at 9:40 AM | markets.businessinsider.comNew to The Street’s Esteemed Client Synergy CHC Corp. (NASDAQ: SNYR) Announces Nationwide EG America Rollout for FOCUSfactor(R) Focus + Energy EG America, 6th Largest U.S ...August 20, 2025 | palmbeachpost.comPSynergy CHC Corp. (NASDAQ: SNYR) Announces Nationwide EG America Rollout for FOCUSfactor® Focus + EnergyAugust 18, 2025 | taiwannews.com.twTNew to The Street's Esteemed Client Synergy CHC Corp. Announces Nationwide EG America Rollout for FOCUSfactor Focus + Energy EG America, 6th Largest U.S. Convenience Chain ...August 18, 2025 | finanznachrichten.deSynergy CHC announces major distribution with for FOCUSfactor Focus + EnergyAugust 18, 2025 | msn.comSynergy CHC Expands FOCUSfactor Distribution with EG AmericaAugust 18, 2025 | tipranks.comAnalysts Set Expectations for Synergy CHC FY2025 EarningsAugust 18, 2025 | americanbankingnews.comSynergy CHC files to sell 1.28M shares of common stockAugust 15, 2025 | msn.comSynergy Chc EPS Jumps 86 Percent in Q2August 15, 2025 | theglobeandmail.comSynergy CHC Corp.: Synergy CHC Corp Reports Second Quarter 2025 Financial Results and its Tenth Consecutive Quarter of ProfitabilityAugust 14, 2025 | finanznachrichten.deSynergy CHC reports Q2 EPS 17c vs 9c last yearAugust 14, 2025 | msn.comSynergy CHC Corp. Reports Strong Second Quarter 2025 Financial Results with Significant Year-over-Year GrowthAugust 14, 2025 | quiverquant.comQSynergy CHC Corp Reports Second Quarter 2025 Financial Results and its Tenth Consecutive Quarter of ProfitabilityAugust 14, 2025 | globenewswire.comNew to The Street TV Commercial Campaigns Achieve Millions of Views with 87% Average Completion RateAugust 5, 2025 | indystar.comINew to The Street Launches 1,000+ Commercial TV Blitz for Synergy CHC ($SNYR), Makers of Focus Factor(R) – Adds NewsOut Video PR Coverage & NYC #1 Market SaturationAugust 5, 2025 | desmoinesregister.comDJack Ross Buys Handful Of Shares In Synergy CHCAugust 3, 2025 | finance.yahoo.comInsider Buying: Synergy CHC Corp. (NASDAQ:SNYR) CEO Purchases 3,750 Shares of StockAugust 1, 2025 | insidertrades.comSynergy CHC Corp. Announces Second Quarter 2025 Earnings and Conference Call InformationJuly 31, 2025 | manilatimes.netMSynergy CHC Corp. Stock (SNYR) Opinions on Retail Distribution ExpansionJuly 31, 2025 | quiverquant.comQNew MarketBeat Followers Over TimeMedia Sentiment Over TimeINBP, SNYR, IGC, and HPPI Company DescriptionsHedgePath Pharmaceuticals OTCMKTS:HPPI$0.06 0.00 (0.00%) As of 08/22/2025HedgePath Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for patients with cancers and non-cancerous proliferation disorders in the United States. It primarily focuses on the development of therapies for skin, lung, and prostate cancers. The company's Hedgehog signaling pathway is a primary regulator of cellular processes in vertebrates, including stem cell maintenance, cell differentiation, tissue polarity, and cell proliferation. It also develops super bioavailability (SUBA)-itraconazole oral capsules for patients with basal cell carcinoma nevus syndrome. SUBA-Itraconazole is a patented itraconazole formulation that enhances the absorption of itraconazole to enhance the bioavailability of orally administered drugs that are poorly soluble. The company was founded in 1992 and is headquartered in Tampa, Florida. HedgePath Pharmaceuticals, Inc. is a subsidiary of Mayne Pharma Ventures Pty Ltd.IGC Pharma NYSEMKT:IGC$0.36 +0.04 (+11.01%) Closing price 08/22/2025 03:58 PM EasternExtended Trading$0.36 0.00 (-0.83%) As of 08/22/2025 07:48 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.IGC Pharma, Inc., a clinical stage pharmaceutical company, engages in developing treatments for Alzheimer's disease. The company's lead product is IGC-AD1, which is in a Phase 2B clinical trial as a treatment for agitation in dementia due to Alzheimer's; and TGR-63, IGC-1C, IGC-M3, and LMP in pre-clinical development. The company was formerly known as India Globalization Capital, Inc. and changed its name to IGC Pharma, Inc. in March 2023. The company was incorporated in 2005 and is headquartered in Potomac, Maryland.Integrated BioPharma OTCMKTS:INBP$0.26 0.00 (0.00%) As of 08/22/2025Integrated BioPharma, Inc., together with its subsidiaries, manufactures, distributes, markets, and sells vitamins, nutritional supplements, and herbal products primarily in the United States and Luxembourg. It operates through Contract Manufacturing and Other Nutraceutical Businesses segments. The Contract Manufacturing segment manufactures vitamins and nutritional supplements for sale to distributors, multilevel marketers, and specialized health-care providers. The Other Nutraceutical Businesses segment distributes healthful nutritional products for sale through mass market, grocery, drug, and vitamin retailers under the Peaceful Sleep and Wheatgrass brands, as well as other branded proprietary nutraceutical products. This segment also sells private label vitamin and nutritional supplement products through the Internet; provides warehousing and fulfilment services; and distributes fine natural botanicals, including multi minerals, as well as raw materials. The company was formerly known as Integrated Health Technologies, Inc. Integrated BioPharma, Inc. was incorporated in 1980 and is based in Hillside, New Jersey.Synergy CHC NASDAQ:SNYR$2.94 +0.04 (+1.38%) As of 08/22/2025 04:00 PM EasternSynergy CHC Corp. engages in the marketing and distribution of branded health and wellness products. The company was founded on December 29, 2010 and is headquartered in Westbrook, ME. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Workday: Institutions Are Buying This Stock, Shouldn’t You? Alphabet’s Breakout Potential: From Laggard to AI Leader After Earnings Miss, Walmart Is Still a Top Consumer Staples Play Should You Join Buffett and Invest in Constellation Brands? Can Identity Security Fuel CrowdStrike’s Next Growth Phase? 3 Robotics Stocks at the Heart of the Robotics Revolution Analog Devices and an AI-Driven Semiconductor Supercycle Shopify’s Risk-Reward Profile Is Suddenly Red Hot Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.